<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03587909</url>
  </required_header>
  <id_info>
    <org_study_id>FLACS1</org_study_id>
    <nct_id>NCT03587909</nct_id>
  </id_info>
  <brief_title>FLACS vs Phaco in Shallow Anterior Chamber</brief_title>
  <official_title>Intraoperative Performance and Postoperative Outcomes Following Femtosecond Laser Assisted Cataract Surgery (FLACS) and Manual Phacoemulsification in Eyes With Shallow Anterior Chamber</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Iladevi Cataract and IOL Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Iladevi Cataract and IOL Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phacoemulsification in eyes with a shallow anterior chamber (ACD &lt; 2.2mm) presents with
      problems of safe access to the cataract and increased vulnerability of the endothelium and a
      higher tendency of complications such as descemet's detachment and iris prolapse. A shallow
      anterior chamber is also responsible for the high incidence of glaucoma and postoperative
      complications after cataract surgery. Femtosecond assisted cataract surgery has made cataract
      surgery safer and more predictable. The effective phacoemulsification time and
      intra-operative manipulation is greatly reduced in FLACS. However phacoemulsification still
      remains the most widely performed cataract surgery around the world. Post-operative outcomes
      after phacoemulsification in patients having shallow anterior chamber have been extensively
      reported in literature over the years.

      There is no head to head comparison in terms of intraoperative performance and post-operative
      outcomes between FLACS and phacoemulsification in eyes with shallow anterior chamber.

      The aim is to compare the intra-operative performance and post-operative outcomes in eyes
      undergoing femtosecond laser assisted cataract surgery versus eyes undergoing
      phacoemulsification in eyes having shallow anterior chamber.

      The study will bring an understanding on the question: Do patients undergoing Femtosecond
      laser assisted cataract surgery behave differently from those undergoing phacoemulsification?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion Criteria:

        -  Age-related cataract

        -  Shallow Anterior Chamber (&lt;2.5mm)

      Exclusion Criteria:

      -Ocular co-morbidity - corneal disorders, glaucoma, uveitis, previous ocular surgery

      Surgical Technique :

        -  Standardized, Single Surgeon

        -  2.2 mm clear corneal temporal incision

        -  FLACS Group : Capsulorhexis, Lens Fragmentation with femto laser

      The investigators will be evaluating the following parameters:

        1. Primary outcome measure Corneal thickness on day 1, week 1 and 1 month (Change in
           corneal thickness of 15% from preop. will be considered significant).

        2. Secondary outcome measures

             -  Corneal clarity -on day 1, week 1 and 1 month postoperatively

             -  Anterior chamber cells and flare (Hogan's criteria)

             -  Percentage change in endothelial cell density from preoperatively to 3 months
                postoperatively

             -  Unaided visual acuity (distance) on day 1 and 1 month.

             -  Best corrected distance visual acuity 1 month postoperatively

        3. Other Observations :

      1) Cumulative Dissipated Energy (CDE) 2) Surgical time 3) Fluid used 4) Descemets membrane
      detachment during surgery 5) Incidence of iris trauma 6) Any other intra-operative
      complications
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">January 15, 2018</completion_date>
  <primary_completion_date type="Actual">December 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Central Corneal Thickness</measure>
    <time_frame>Postoperative Day 1</time_frame>
    <description>Central Corneal Thickness</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anterior Chamber Inflammation</measure>
    <time_frame>Postoperative Day 1</time_frame>
    <description>Anterior chamber cells and flare (Hogan's criteria)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial Cell Morphology</measure>
    <time_frame>Postoperative 6 months</time_frame>
    <description>Endothelial Cell Density</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">91</enrollment>
  <condition>Cataract Surgery</condition>
  <condition>Shallow Anterior Chamber</condition>
  <condition>Phacoemulsification</condition>
  <arm_group>
    <arm_group_label>Phacoemulsification Cataract Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Procedure / Surgery : Phacoemulsification Surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Femtosecond Cataract Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Procedure / SUrgery - Femtosecond Laser Cataract surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phacoemulsification Cataract SUrgery</intervention_name>
    <description>Phacoemulsification in eyes with shallow anterior chamber (&lt;2.5mm depth)</description>
    <arm_group_label>Phacoemulsification Cataract Surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Femtosecond Cataract Surgery</intervention_name>
    <description>Femtosecond Cataract Surgery in eyes with shallow anterior chamber &lt; 2.5mm</description>
    <arm_group_label>Femtosecond Cataract Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  uncomplicated, age related cataracts

          -  Shallow anterior chamber (measured as &lt;/=2.5mm )

        Exclusion Criteria:

          -  Coexisting ocular morbidity,

          -  inability to come for followup
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abhay Vasavada, MS,FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Iladevi Cataract &amp; IOL Research Centre, Ahmedabad</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Iladevi Cataract &amp; IOL Research Center</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380052</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 11, 2018</study_first_submitted>
  <study_first_submitted_qc>July 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2018</study_first_posted>
  <last_update_submitted>July 3, 2018</last_update_submitted>
  <last_update_submitted_qc>July 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Iladevi Cataract and IOL Research Center</investigator_affiliation>
    <investigator_full_name>Abhay R. Vasavada</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>FLACS</keyword>
  <keyword>Phaco</keyword>
  <keyword>Shallow Anterior Chamber</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

